Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 1
2010 1
2011 3
2012 1
2013 2
2014 1
2015 4
2017 1
2018 1
2019 4
2020 7
2021 4
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Eosinophils in innate immunity: an evolving story.
Shamri R, Xenakis JJ, Spencer LA. Shamri R, et al. Among authors: xenakis jj. Cell Tissue Res. 2011 Jan;343(1):57-83. doi: 10.1007/s00441-010-1049-6. Epub 2010 Nov 3. Cell Tissue Res. 2011. PMID: 21042920 Free PMC article. Review.
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.
Landis MN, Arya M, Smith S, Draelos Z, Usdan L, Tarabar S, Pradhan V, Aggarwal S, Banfield C, Peeva E, Vincent MS, Sikirica V, Xenakis J, Beebe JS. Landis MN, et al. Among authors: xenakis j. Br J Dermatol. 2022 Dec;187(6):878-887. doi: 10.1111/bjd.21826. Epub 2022 Oct 23. Br J Dermatol. 2022. PMID: 35986699 Free PMC article. Clinical Trial.
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment.
Feldman SR, Thyssen JP, Boeri M, Gerber R, Neary MP, Cha A, Hauber B, Cappelleri JC, Xenakis J, Leach C, Zeichner J. Feldman SR, et al. Among authors: xenakis j. J Dermatolog Treat. 2024 Dec;35(1):2304020. doi: 10.1080/09546634.2024.2304020. Epub 2024 Jan 14. J Dermatolog Treat. 2024. PMID: 38221777 Free article.
Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse.
Yu W, Hill SF, Xenakis JG, Pardo-Manuel de Villena F, Wagnon JL, Meisler MH. Yu W, et al. Among authors: xenakis jg. Epilepsia. 2020 Dec;61(12):2847-2856. doi: 10.1111/epi.16741. Epub 2020 Nov 2. Epilepsia. 2020. PMID: 33140451 Free PMC article.
Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study.
Duncan PW, Bushnell CD, Jones SB, Psioda MA, Gesell SB, D'Agostino RB Jr, Sissine ME, Coleman SW, Johnson AM, Barton-Percival BF, Prvu-Bettger J, Calhoun AG, Cummings DM, Freburger JK, Halladay JR, Kucharska-Newton AM, Lundy-Lamm G, Lutz BJ, Mettam LH, Pastva AM, Xenakis JG, Ambrosius WT, Radman MD, Vetter B, Rosamond WD; COMPASS Site Investigators and Teams.. Duncan PW, et al. Among authors: xenakis jg. Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006285. doi: 10.1161/CIRCOUTCOMES.119.006285. Epub 2020 Jun 1. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32475159 Free article. Clinical Trial.
38 results